Lv31
240 积分 2025-04-25 加入
The challenge of molecular stratification in No Specific Molecular Profile endometrial cancer
1个月前
已完结
Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
2个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
2个月前
已完结
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma
2个月前
已关闭
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
2个月前
已完结
Hallmarks of cancer-Then and now, and beyond
2个月前
已完结
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025
4个月前
已完结
Cholesterol desensitizes the response of endometrial cancer to progestin by attenuating progestin signaling
4个月前
已完结
Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer: a systematic review and meta-analysis
4个月前
已完结
Ovarian Cancer
4个月前
已完结
皖公网安备34019202002308
